Related Experiment Videos
The use of diltiazem hydrochloride in cardiovascular disorders
Insights
Diltiazem, a calcium channel blocker, effectively treats various cardiovascular conditions like angina and supraventricular tachycardia by improving blood flow and heart function. This well-tolerated medication offers significant benefits with minimal adverse effects.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Diltiazem is a calcium channel blocking agent with significant cardiovascular effects.
- Its actions target vascular smooth muscle, ventricular myocardium, and cardiac conducting tissues.
Purpose of the Study:
- To explore the diverse cardiovascular applications of diltiazem.
- To evaluate its efficacy in conditions such as variant angina, exertional angina, and supraventricular tachycardia.
Main Methods:
- The study reviews diltiazem's pharmacological profile, including its vasodilatory and electrophysiological effects.
- Clinical efficacy is assessed through comparisons with other treatments and preliminary data analysis.
Main Results:
- Diltiazem demonstrates effectiveness in relieving coronary artery spasm and shows comparable efficacy to nitrates for exertional angina.
- It is effective in treating re-entrant supraventricular tachycardia and shows promise for unstable angina and acute myocardial ischemia.
Conclusions:
- Diltiazem is a versatile cardiovascular agent with proven efficacy in multiple conditions.
- Its favorable side effect profile, with adverse effects in less than 5% of patients, indicates good tolerability.
Abstract:
Diltiazem, a calcium channel blocking agent, has potent cardiovascular effects that are directly related to its influence on vascular smooth muscle, ventricular myocardium, and specialized conducting tissue. It causes coronary and peripheral vasodilation, has a negative chronotropic and dromotropic effect, and little to no negative inotropic effect in patients with normal ventricular function. Diltiazem has potential use in a wide variety of cardiovascular disorders. It has been shown extremely effective in relieving the coronary artery spasm associated with variant angina. When compared with nitrates in patients with exertional angina, diltiazem has similar efficacy. Preliminary work indicates it will have a therapeutic role in the treatment of unstable angina. Because of its ability to improve the balance between myocardial oxygen supply and demand and reduce cellular injury secondary to ischemia, it is likely that diltiazem will be of benefit in the treatment of acutely ischemic myocardium during cardiopulmonary bypass and possibly acute myocardial infarction. It has proven efficacy in treating re-entrant supraventricular tachycardia. Adverse effects are seen in less than 5% of patients, indicating that it is well tolerated.